International Journal of Molecular Sciences, Volume 24, Issue 15
2023 August-1 - 659 articles
Cover Story: Bladder cancer is the sixth most common cancer amongst males (Globocan 2020). It is characterized by frequent recurrences after surgical removal of the tumor. The gold standard therapy is Mycobacterium bovis, Bacillus Calmette Guérin (BCG) immunotherapy. But a significant proportion of patients fail this therapy. Despite more than 50 years of clinical use, there has been little progress in improving the response to BCG immunotherapy, and newer therapies have only had an incremental improvement in response. An understanding of the bladder tumor environment, especially the cell types that populate and modulate this space, may identify new strategies to improve patient outcomes. This review examines the components of the bladder tumor environment. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.